These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

160 related items for PubMed ID: 32445051

  • 21. Treatment of ulcerative colitis with Wu-Mei-Wan by inhibiting intestinal inflammatory response and repairing damaged intestinal mucosa.
    Yan S, Wang P, Wei H, Jia R, Zhen M, Li Q, Xue C, Li J.
    Phytomedicine; 2022 Oct; 105():154362. PubMed ID: 35947900
    [Abstract] [Full Text] [Related]

  • 22. Qingchang Wenzhong Decoction ameliorates intestinal inflammation and intestinal barrier dysfunction in ulcerative colitis via the GC-C signaling pathway.
    Zhang Y, Li J, Han X, Jiang H, Wang J, Wang M, Zhang X, Zhang L, Hu J, Fu Z, Shi L.
    J Ethnopharmacol; 2024 Mar 25; 322():117503. PubMed ID: 38043755
    [Abstract] [Full Text] [Related]

  • 23. Microbiota from patients with ulcerative colitis promote colorectal carcinogenesis in mice.
    Tian Y, Zuo L, Guan B, Wu H, He Y, Xu Z, Shen M, Hu J, Qian J.
    Nutrition; 2022 Oct 25; 102():111712. PubMed ID: 35802940
    [Abstract] [Full Text] [Related]

  • 24. Aberrant methylation of DAPK in long-standing ulcerative colitis and ulcerative colitis-associated carcinoma.
    Kuester D, Guenther T, Biesold S, Hartmann A, Bataille F, Ruemmele P, Peters B, Meyer F, Schubert D, Bohr UR, Malfertheiner P, Lippert H, Silver AR, Roessner A, Schneider-Stock R.
    Pathol Res Pract; 2010 Sep 15; 206(9):616-24. PubMed ID: 20630662
    [Abstract] [Full Text] [Related]

  • 25. Practical fecal calprotectin cut-off value for Japanese patients with ulcerative colitis.
    Urushikubo J, Yanai S, Nakamura S, Kawasaki K, Akasaka R, Sato K, Toya Y, Asakura K, Gonai T, Sugai T, Matsumoto T.
    World J Gastroenterol; 2018 Oct 14; 24(38):4384-4392. PubMed ID: 30344422
    [Abstract] [Full Text] [Related]

  • 26. Endoscopic finding of spontaneous hemorrhage correlates with tumor necrosis factor alpha expression in colonic mucosa of patients with ulcerative colitis.
    Hozumi H, Hokari R, Kurihara C, Narimatsu K, Sato H, Sato S, Ueda T, Higashiyama M, Okada Y, Watanabe C, Komoto S, Tomita K, Kawaguchi A, Nagao S, Miura S.
    Int J Colorectal Dis; 2013 Aug 14; 28(8):1049-55. PubMed ID: 23377880
    [Abstract] [Full Text] [Related]

  • 27. Association of PTPN22 gene (rs2488457) polymorphism with ulcerative colitis and high levels of PTPN22 mRNA in ulcerative colitis.
    Chen Z, Zhang H, Xia B, Wang P, Jiang T, Song M, Wu J.
    Int J Colorectal Dis; 2013 Oct 14; 28(10):1351-8. PubMed ID: 23456301
    [Abstract] [Full Text] [Related]

  • 28. Increased intestinal expression of heme oxygenase-1 and its localization in patients with ulcerative colitis.
    Takagi T, Naito Y, Mizushima K, Nukigi Y, Okada H, Suzuki T, Hirata I, Omatsu T, Okayama T, Handa O, Kokura S, Ichikawa H, Yoshikawa T.
    J Gastroenterol Hepatol; 2008 Dec 14; 23 Suppl 2():S229-33. PubMed ID: 19120903
    [Abstract] [Full Text] [Related]

  • 29. Interferon-inducible gene family 1-8U expression in colitis-associated colon cancer and severely inflamed mucosa in ulcerative colitis.
    Hisamatsu T, Watanabe M, Ogata H, Ezaki T, Hozawa S, Ishii H, Kanai T, Hibi T.
    Cancer Res; 1999 Dec 01; 59(23):5927-31. PubMed ID: 10606237
    [Abstract] [Full Text] [Related]

  • 30. Integrated miRNA and mRNA expression profiling in inflamed colon of patients with ulcerative colitis.
    Van der Goten J, Vanhove W, Lemaire K, Van Lommel L, Machiels K, Wollants WJ, De Preter V, De Hertogh G, Ferrante M, Van Assche G, Rutgeerts P, Schuit F, Vermeire S, Arijs I.
    PLoS One; 2014 Dec 01; 9(12):e116117. PubMed ID: 25546151
    [Abstract] [Full Text] [Related]

  • 31. Cytokine profile in colonic mucosa of ulcerative colitis correlates with disease activity and response to granulocytapheresis.
    Tsukada Y, Nakamura T, Iimura M, Iizuka BE, Hayashi N.
    Am J Gastroenterol; 2002 Nov 01; 97(11):2820-8. PubMed ID: 12425554
    [Abstract] [Full Text] [Related]

  • 32. KFL2 participates in the development of ulcerative colitis through inhibiting inflammation via regulating cytokines.
    Wang ZL, Wang YD, Wang K, Li JA, Li L.
    Eur Rev Med Pharmacol Sci; 2018 Aug 01; 22(15):4941-4948. PubMed ID: 30070340
    [Abstract] [Full Text] [Related]

  • 33. Toll-like receptor 2 monoclonal antibody or/and Toll-like receptor 4 monoclonal antibody increase counts of Lactobacilli and Bifidobacteria in dextran sulfate sodium-induced colitis in mice.
    Dong L, Li J, Liu Y, Yue W, Luo X.
    J Gastroenterol Hepatol; 2012 Jan 01; 27(1):110-9. PubMed ID: 21722182
    [Abstract] [Full Text] [Related]

  • 34. MiR-29a promotes intestinal epithelial apoptosis in ulcerative colitis by down-regulating Mcl-1.
    Lv B, Liu Z, Wang S, Liu F, Yang X, Hou J, Hou Z, Chen B.
    Int J Clin Exp Pathol; 2014 Jan 01; 7(12):8542-52. PubMed ID: 25674218
    [Abstract] [Full Text] [Related]

  • 35. Downregulation of electroacupuncture at ST36 on TNF-alpha in rats with ulcerative colitis.
    Tian L, Huang YX, Tian M, Gao W, Chang Q.
    World J Gastroenterol; 2003 May 01; 9(5):1028-33. PubMed ID: 12717850
    [Abstract] [Full Text] [Related]

  • 36. Soluble syndecan-1 as marker of intestinal inflammation: A preliminary study and evaluation of a new panel of biomarkers for non-invasive prediction of active ulcerative colitis.
    Floer M, Clausen M, Meister T, Vollenberg R, Bettenworth D, Tepasse PR.
    Adv Clin Exp Med; 2021 Jul 01; 30(7):655-660. PubMed ID: 34286513
    [Abstract] [Full Text] [Related]

  • 37. Increased expression of NKX2.3 mRNA transcribed from the risk haplotype for ulcerative colitis in the involved colonic mucosa.
    Arai T, Kakuta Y, Kinouchi Y, Kimura T, Negoro K, Aihara H, Endo K, Shiga H, Kanazawa Y, Kuroha M, Moroi R, Nagasawa H, Shimodaira Y, Takahashi S, Shimosegawa T.
    Hum Immunol; 2011 Jul 01; 72(7):587-91. PubMed ID: 21514341
    [Abstract] [Full Text] [Related]

  • 38. Fecal MMP-9: a new noninvasive differential diagnostic and activity marker in ulcerative colitis.
    Annaházi A, Molnár T, Farkas K, Rosztóczy A, Izbéki F, Gecse K, Inczefi O, Nagy F, Földesi I, Szűcs M, Dabek M, Ferrier L, Theodorou V, Bueno L, Wittmann T, Róka R.
    Inflamm Bowel Dis; 2013 Feb 01; 19(2):316-20. PubMed ID: 22550024
    [Abstract] [Full Text] [Related]

  • 39. The function of Sphingosine-1-phosphate receptor 2 (S1PR2) in maintaining intestinal barrier and inducing ulcerative colitis.
    Chen T, Gu K, Lin R, Liu Y, Shan Y.
    Bioengineered; 2022 May 01; 13(5):13703-13717. PubMed ID: 35707833
    [Abstract] [Full Text] [Related]

  • 40. Serum leucine-rich alpha-2 glycoprotein is a disease activity biomarker in ulcerative colitis.
    Serada S, Fujimoto M, Terabe F, Iijima H, Shinzaki S, Matsuzaki S, Ohkawara T, Nezu R, Nakajima S, Kobayashi T, Plevy SE, Takehara T, Naka T.
    Inflamm Bowel Dis; 2012 Nov 01; 18(11):2169-79. PubMed ID: 22374925
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.